NCT03305809: A reported trial by Eli Lilly and Company
This trial has reported on time, in line with the regulations.
Full data
| Full entry on ClinicalTrials.gov | NCT03305809 |
|---|---|
| Title | Effect of LY3154207 on Cognition in Mild-to-Moderate Dementia Due to Lewy Body Dementia (LBD) Associated With Idiopathic Parkinson's Disease (PD) or Dementia With Lewy Bodies (DLB) |
| Results Status | Reported |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | Nov. 9, 2017 |
| Completion date | July 10, 2020 |
| Required reporting date | July 10, 2021, midnight |
| Actual reporting date | July 2, 2021 |
| Date last checked at ClinicalTrials.gov | Feb. 9, 2024 |
| Days late | None |